While Afghanistan sinks back into the muck of religious extremism that frightened even the ayatollahs in Iran, the leaders of the de facto Kurdistan are rediscovering what sort of friend they have been relying on with Turkey being aided in its genocide of Kurds by the U.S.. South America’s democracies in open revolt against the hegemony of the norteamericans, a far more important war than all of those combined is flagging under assault from the left and corporate interests.
That is the War on Cancer initiated by that old reprobate, Dick Nixon.
Doctors don’t need more cancer drugs one Naderite told me. Oncologists don’t know which to select now.
Maybe one that works might be nice, I helpfully suggested.
While the anemic pipelines of the copycat drugs of Big Pharma continue to shrivel and patents on their marketed drugs continue to age and expire, emphasis is increasingly turning towards competing in generics and promotion. The wellspring of true innovation, the small biotechs, is drying up like the melting dew under the glare of journalists, rape by offshore lenders and other fine financiers, attack by the hedge funds and an increasingly hostile FDA.
Just imagine if we offered Pakistanis and Iraqis and Afghanis and others around the world novel new cures and treatments for deadly diseases, as we once did, instead of guns and bombs and bullets and money for dirty birds.
Wouldn’t want to do that.
Who would they have to hate?
Everyone needs enemies to make progress.